TRV NYSE Property & Casualty Insurance Financials FY2016–FY2025
Travelers Companies had $48.8B of revenue in fiscal 2025, up 5.2% on the year before. Over five years, revenue changed +8.8% a year on average.
Hi! I read Travelers Companies’s latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+5.2%
Yes. Sales grew 5.2% last year.
Does it make a profit?
12.9%
Yes. It keeps 12.9% of every sale as profit.
Is debt under control?
0.3x
Yes. It could repay its debt with 0.3 years of operating profit.
How is the share priced?
10.5x
One share costs 10.5 times its yearly profit per share. Typical for its sector: 13.7x.
Rules of thumb on reported numbers. A starting point, not a recommendation.
About these figures. Debt is the total of Travelers' long-term and short-term debt, including its commercial paper, as its filings tag it. Travelers's cash flow statement doesn't show its spending on property and equipment as a line of its own, so capital spending and free cash flow are left blank.
Is it selling more, and how much does it keep?
KIRA · Travelers Companies had $48.8B of revenue in fiscal 2025, up 5.2% on the year before. Over five years, revenue changed +8.8% a year on average.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA · Travelers Companies made $6.3B of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew 11.5% a year.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
KIRA · Travelers Companies returned $4.0B to shareholders in fiscal 2025. The diluted share count fell 1.5%.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA · In the last 12 months, insiders sold $168M of shares on the open market and bought none.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$168M
14 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 22, 2026 | Gregory C ToczydlowskiEVP & President, Business Ins. | Sold | 34,771 | $403.89 | $14.0M | Form 4 |
| Oct 22, 2026 | Jeffrey P. KlenkEVP & Pres., Bond & Spec. Ins. | Sold | 9,016 | $405.57 | $3.7M | Form 4 |
| Oct 22, 2026 | David Donnay RowlandEVP & Co-Chief Invest. Officer | Sold | 5,000 | $405.62 | $2.0M | Form 4 |
| Oct 21, 2026 | Alan D SchnitzerChairman and CEO, Director | Sold | 88,900 | $396.77 | $35.3M | Form 4 |
| Oct 21, 2026 | Maria OlivoEVP, ERM & Chief Risk Officer | Sold | 15,100 | $398.44 | $6.0M | Form 4 |
| Oct 20, 2026 | Michael Frederick KleinEVP & President, Personal Ins. | Sold | 7,500 | $392.79 | $2.9M | Form 4 |
| Aug 28, 2026 | Maria OlivoEVP, ERM & Chief Risk Officer | Sold | 6,000 | $369.86 | $2.2M | Form 4 |
| Jul 24, 2026 | Diane KurtzmanEVP & Chief HR Officer | Sold | 4,164 | $386.71 | $1.6M | Form 4 |
| Jul 24, 2026 | Daniel Tei-Hwa YinEVP & Co-Chief Invest. Officer | Sold | 7,153 | $387.00 | $2.8M | Form 4 |
| Jul 22, 2026 | David Donnay RowlandEVP & Co-Chief Invest. Officer | Sold | 5,000 | $371.69 | $1.9M | Form 4 |
| Jul 22, 2026 | Andy F BessetteEVP and Chief Admin Officer | Sold | 3,000 | $368.12 | $1.1M | Form 4 |
| Jul 22, 2026 | Paul E. MunsonSVP & Corp. Controller | Sold | 1,525 | $369.91 | $0.6M | Form 4 |
| Jul 21, 2026 | Daniel S. FreyEVP & Chief Financial Officer | Sold | 14,037 | $368.24 | $5.2M | Form 4 |
| Jul 21, 2026 | Michael Frederick KleinEVP & President, Personal Ins. | Sold | 6,000 | $366.09 | $2.2M | Form 4 |
| Jul 21, 2026 | Mojgan M LefebvreEVP & Chief Tech & Ops Officer | Sold | 16,313 | $368.38 | $6.0M | Form 4 |
| May 26, 2026 | Michael Frederick KleinEVP & President, Personal Ins. | Sold | 10,000 | $307.65 | $3.1M | Form 4 |
| May 22, 2026 | Andy F BessetteEVP and Chief Admin Officer | Sold | 4,255 | $308.11 | $1.3M | Form 4 |
| Apr 28, 2026 | William H HeymanVice Chairman | Sold | 1,557 | $310.64 | $0.5M | Form 4 |
| Apr 28, 2026 | Avrohom J. KessVice Chmn. & Chief Legal Off. | Sold | 6,735 | $308.78 | $2.1M | Form 4 |
| Apr 20, 2026 | Diane KurtzmanEVP & Chief HR Officer | Sold | 2,867 | $303.45 | $0.9M | Form 4 |
| Apr 20, 2026 | Jeffrey P. KlenkEVP & Pres., Bond & Spec. Ins. | Sold | 6,414 | $305.06 | $2.0M | Form 4 |
| Apr 20, 2026 | Michael Frederick KleinEVP & President, Personal Ins. | Sold | 10,000 | $303.77 | $3.0M | Form 4 |
| Feb 26, 2026 | Maria OlivoEVP, ERM & Chief Risk Officer | Sold | 10,400 | $306.60 | $3.2M | Form 4 |
| Feb 26, 2026 | David Donnay RowlandEVP & Co-Chief Invest. Officer | Sold | 4,731 | $308.52 | $1.5M | Form 4 |
| Feb 25, 2026 | Paul E. MunsonSVP & Corp. Controller | Sold | 3,727 | $306.04 | $1.1M | Form 4 |
| Feb 23, 2026 | William H HeymanVice Chairman | Sold | 4,000 | $307.44 | $1.2M | Form 4 |
| Feb 20, 2026 | William H HeymanVice Chairman | Sold | 1,000 | $304.00 | $0.3M | Form 4 |
| Feb 20, 2026 | Avrohom J. KessVice Chmn & Chief Legal Off | Sold | 4,756 | $300.44 | $1.4M | Form 4 |
| Feb 20, 2026 | Gregory C ToczydlowskiEVP & President, Business Ins. | Sold | 12,200 | $299.76 | $3.7M | Form 4 |
| Feb 20, 2026 | Daniel S. FreyEVP & Chief Financial Officer | Sold | 8,000 | $299.50 | $2.4M | Form 4 |
| Feb 19, 2026 | Mojgan M LefebvreEVP & Chief Tech & Ops Officer | Sold | 5,827 | $298.25 | $1.7M | Form 4 |
| Feb 17, 2026 | Andy F BessetteEVP and Chief Admin Officer | Sold | 6,000 | $297.66 | $1.8M | Form 4 |
| Feb 17, 2026 | William H HeymanVice Chairman | Sold | 1,000 | $300.00 | $0.3M | Form 4 |
| Feb 6, 2026 | Maria OlivoEVP, ERM & Chief Risk Officer | Sold | 10,400 | $300.75 | $3.1M | Form 4 |
| Feb 6, 2026 | William H HeymanVice Chairman | Sold | 1,000 | $303.00 | $0.3M | Form 4 |
| Feb 6, 2026 | Michael Frederick KleinEVP & President, Personal Ins. | Sold | 10,000 | $301.18 | $3.0M | Form 4 |
| Feb 5, 2026 | William H HeymanVice Chairman | Sold | 5,000 | $302.00 | $1.5M | Form 4 |
| Feb 4, 2026 | Alan D SchnitzerChairman and CEO, Director | Sold | 55,733 | $294.70 | $16.4M | Form 4 |
| Jan 23, 2026 | Jeffrey P. KlenkEVP & Pres., Bond & Spec. Ins. | Sold | 16,712 | $279.77 | $4.7M | Form 4 |
| Nov 26, 2025 | Maria OlivoEVP, Strat Dev & Pres Intl | Sold | 8,920 | $295.73 | $2.6M | Form 4 |
| Nov 25, 2025 | William H HeymanVice Chairman | Sold | 4,000 | $294.51 | $1.2M | Form 4 |
| Nov 24, 2025 | Diane KurtzmanEVP & Chief HR Officer | Sold | 4,805 | $290.00 | $1.4M | Form 4 |
| Nov 21, 2025 | David Donnay RowlandEVP & Co-Chief Invest. Officer | Sold | 5,000 | $290.57 | $1.5M | Form 4 |
| Nov 21, 2025 | William H HeymanVice Chairman | Sold | 2,000 | $291.50 | $0.6M | Form 4 |
| Nov 13, 2025 | William H HeymanVice Chairman | Sold | 1,803 | $289.55 | $0.5M | Form 4 |
| Nov 12, 2025 | William H HeymanVice Chairman | Sold | 2,000 | $287.50 | $0.6M | Form 4 |
| Nov 11, 2025 | William H HeymanVice Chairman | Sold | 4,000 | $284.70 | $1.1M | Form 4 |
| Nov 10, 2025 | William H HeymanVice Chairman | Sold | 2,000 | $281.50 | $0.6M | Form 4 |
| Nov 7, 2025 | William H HeymanVice Chairman | Sold | 1,000 | $280.00 | $0.3M | Form 4 |
| Nov 6, 2025 | Daniel S. FreyEVP & Chief Financial Officer | Sold | 25,000 | $278.25 | $7.0M | Form 4 |
| Oct 28, 2025 | Michael Frederick KleinEVP & President, Personal Ins. | Sold | 8,572 | $270.73 | $2.3M | Form 4 |
Can it carry its debts, and how well does it use its money?
KIRA · Travelers Companies owes $2.7B more than it holds in cash, about 0.3 years of operating profit.
Cash, debt and the ratios that show how comfortably Travelers Companies can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $4.6B | $4.3B | $5.8B | $5.5B | $6.6B |
| Debt incl. finance leases | $7.3B | $7.3B | $8.0B | $8.0B | $9.3B |
| Net debt / EBITDA | 0.5x | 0.7x | 0.5x | 0.4x | 0.3x |
| Debt / equity | 0.3x | 0.3x | 0.3x | 0.3x | 0.3x |
| Interest coverage | 14.1x | 10.6x | 10.0x | 16.8x | 19.3x |
| Total assets | $120.5B | $115.7B | $126.0B | $133.2B | $143.7B |
| Total liabilities | $91.6B | $94.2B | $101.1B | $105.3B | $110.8B |
| Shareholders' equity | $28.9B | $21.6B | $24.9B | $27.9B | $32.9B |
| Net debt (− = net cash) | $2.7B | $3.0B | $2.2B | $2.6B | $2.7B |
KIRA · Its return on capital was 20.1%: every 100 invested in the business earned about 20 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ |
| Return on assets rose | ✓ | ✓ | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ |
| Debt fell relative to assets | ✕ | ✓ | ✕ |
| Current ratio rose | — | — | — |
| Share count didn't rise | ✓ | ✓ | ✓ |
| Gross margin rose | — | — | — |
| Revenue rose relative to assets | ✓ | ✓ | ✕ |
| F-score | — / 9 | — / 9 | — / 9 |
| Accruals ratio | −3.9% | −3.1% | −3.1% |
| Altman Z'' | — | — | — |
What does the share cost, and how does it compare?
KIRA · At $400.17 a share, the company is worth $84.3B: 10.5 times its earnings of the last four quarters.
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.
In plain words: Move the sliders to try your own guesses about growth. The result is what one share would be worth if those guesses came true. Different guesses give very different answers.
Value per share
—
Adds net cash of −$2.7B and divides by 227.6M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Value per share
—
Reference multiples: today 10.5x · peers 10.1x · sector 13.7x.
KIRA · Travelers Companies grew sales faster than 0 of its 4 similar companies. Its P/E is higher than 2 of 4.
Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.
In plain words: The same numbers for similar companies, so you can tell whether a figure is high or low for this kind of business.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Travelers Companies TRV | $84.3B | 5.2% | — | — | 20.1% | 10.5x | — | |
| Chubb CB | $140.8B | 6.5% | — | — | 13.6% | 12.6x | — | Compare → |
| Allstate ALL | $66.3B | 5.6% | — | 14.6% | 37.3% | 5.1x | — | Compare → |
| Hartford HIG | $37.6B | 6.9% | — | 20.3% | 22.6% | 8.8x | — | Compare → |
| Progressive PGR | $133.9B | 16.3% | — | 19.6% | 39.2% | 11.5x | — | Compare → |
Every number, year by year.
Amounts in USD. Hover a ratio’s name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $27.6B | $28.9B | $30.3B | $31.6B | $32.0B | $34.8B | $36.9B | $41.4B | $46.4B | $48.8B |
| Interest expense | $363M | $369M | $352M | $344M | $339M | $340M | $351M | $376M | $392M | $425M |
| Pretax income | $4.1B | $2.7B | $3.0B | $3.1B | $3.2B | $4.5B | $3.4B | $3.4B | $6.2B | $7.8B |
| Income tax | $1.0B | $674M | $438M | $516M | $540M | $796M | $512M | $380M | $1.2B | $1.5B |
| Net income | $3.0B | $2.1B | $2.5B | $2.6B | $2.7B | $3.7B | $2.8B | $3.0B | $5.0B | $6.3B |
| Diluted EPS | $10.28 | $7.33 | $9.28 | $9.92 | $10.52 | $14.49 | $11.77 | $12.79 | $21.47 | $27.43 |
| Diluted shares | 0.29B | 0.28B | 0.27B | 0.26B | 0.25B | 0.25B | 0.24B | 0.23B | 0.23B | 0.23B |
| Cash flow | ||||||||||
| Cash from operations | $4.5B | $4.1B | $4.4B | $5.2B | $6.5B | $7.3B | $6.5B | $7.7B | $9.1B | $10.6B |
| Depreciation and amortization | $826M | $813M | $803M | $763M | $789M | $870M | $826M | $722M | $715M | $680M |
| Stock-based compensation | $155M | $136M | $140M | $142M | $148M | $162M | $183M | $214M | $260M | $256M |
| Acquisitions | $0.0M | $439M | $4.0M | $0.0M | $0.0M | $38.0M | $4.0M | $0.0M | $382M | $0.0M |
| Share buybacks | $2.4B | $1.4B | $1.3B | $1.5B | $625M | $2.2B | $2.0B | $958M | $1.0B | $3.0B |
| Dividends paid | $757M | $785M | $814M | $844M | $861M | $869M | $875M | $908M | $951M | $979M |
| Dividends and buybacks | $3.2B | $2.2B | $2.1B | $2.3B | $1.5B | $3.0B | $2.9B | $1.9B | $2.0B | $4.0B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $5.2B | $5.2B | $4.4B | $5.4B | $6.2B | $4.6B | $4.3B | $5.8B | $5.5B | $6.6B |
| Total debt | $6.4B | $6.6B | $6.6B | $6.6B | $6.6B | $7.3B | $7.3B | $8.0B | $8.0B | $9.3B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Total assets | $100.2B | $103.5B | $104.2B | $110.1B | $116.8B | $120.5B | $115.7B | $126.0B | $133.2B | $143.7B |
| Total liabilities | $77.0B | $79.8B | $81.3B | $84.2B | $87.6B | $91.6B | $94.2B | $101.1B | $105.3B | $110.8B |
| Shareholders' equity | $23.2B | $23.7B | $22.9B | $25.9B | $29.2B | $28.9B | $21.6B | $24.9B | $27.9B | $32.9B |
| Margins | ||||||||||
| EBITDA margin | 19.0% | 13.5% | 13.6% | 13.4% | 13.7% | 16.3% | 12.3% | 10.8% | 15.7% | 18.2% |
| Net margin | 10.9% | 7.1% | 8.3% | 8.3% | 8.4% | 10.5% | 7.7% | 7.2% | 10.8% | 12.9% |
| Returns | ||||||||||
| Return on capital | 13.3% | 9.4% | 11.3% | 11.2% | 10.5% | 12.9% | 11.2% | 12.9% | 18.5% | 20.1% |
| Return on equity | 12.9% | 8.8% | 10.8% | 10.7% | 9.8% | 12.6% | 11.3% | 12.9% | 18.9% | 20.7% |
| Return on assets | 3.0% | 2.0% | 2.4% | 2.5% | 2.4% | 3.1% | 2.4% | 2.5% | 3.9% | 4.5% |
| Growth | ||||||||||
| Revenue growth | 3.0% | 4.6% | 4.8% | 4.3% | 1.3% | 8.9% | 5.9% | 12.2% | 12.2% | 5.2% |
| Net income growth | −12.4% | −31.8% | 22.7% | 3.9% | 2.9% | 35.8% | −22.4% | 5.2% | 67.1% | 25.8% |
| EPS growth | −5.5% | −28.7% | 26.6% | 6.9% | 6.1% | 37.7% | −18.8% | 8.7% | 67.9% | 27.8% |
| Share count change | −7.3% | −4.3% | −3.2% | −2.8% | −2.9% | −1.5% | −4.4% | −3.1% | −0.5% | −1.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.2x | 0.3x | 0.5x | 0.3x | 0.1x | 0.5x | 0.7x | 0.5x | 0.4x | 0.3x |
| Debt / equity | 0.3x | 0.3x | 0.3x | 0.3x | 0.2x | 0.3x | 0.3x | 0.3x | 0.3x | 0.3x |
| Interest coverage | 12.2x | 8.4x | 9.4x | 10.1x | 10.6x | 14.1x | 10.6x | 10.0x | 16.8x | 19.3x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 0.6% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.6% | 0.5% |
| Quality scores | ||||||||||
| Accruals ratio | −1.5% | −2.1% | −1.8% | −2.4% | −3.4% | −3.1% | −3.1% | −3.9% | −3.1% | −3.1% |
Source: SEC EDGAR XBRL filings (CIK 0000086312). Data updated October 16, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
